Printer Friendly

JACOBS SELECTED BY ELI LILLY AND CO. TO DESIGN BIOTECHNOLOGY DEVELOPMENT LABORATORIES

 JACOBS SELECTED BY ELI LILLY AND CO. TO DESIGN
 BIOTECHNOLOGY DEVELOPMENT LABORATORIES
 CINCINNATI, Aug. 19 /PRNewswire/ -- Jacobs Engineering Group Inc. (NYSE: JEC) announced today that it's subsidiary, Jacob Engineering of Ohio, has been selected to perform design services for a $125 million Biotechnology Development Laboratories for Eli Lilly and Co. The building is part of the overall development of Lilly Technology Center in Indianapolis and will bring together related product development, manufacturing, distribution and administrative functions.
 The new facility's state-of-the-art laboratories and pilot plant operations will be used primarily for the development of large-scale production processes for new medicines from biotechnology, mainly using recombinant DNA and fermentation technology.
 Groundbreaking for the building was held in July 1992 with completion expected for spring 1995. The building will be designed with future expansion in mind and will have six levels totaling nearly 300,000 square feet. When the building is fully occupied, it will house 300 engineers, scientists, technicians and support personnel.
 Jacobs Engineering Group, headquartered in Pasadena, Calif., provides single-source consulting, engineering, design, architectural, environmental and hazardous waste management, procurement, construction, construction management, contract maintenance and operations services to government and industry worldwide. Jacobs has 23 offices located throughout the United States and Ireland with a major office in Cincinnati.
 -0- 8/19/92
 /CONTACT: Robert M. Clement of Jacobs Engineering, 818-578-6902/
 (JEC) CO: Jacobs Engineering Group Inc.; Eli Lilly and Co. ST: Ohio, California IN: CST SU: CON


AL -- LA001 -- 1197 08/19/92 08:08 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 19, 1992
Words:247
Previous Article:AMWAY PRESENTS $50,000 AMWAY/EBONY ENVIRONMENTAL SCHOLARSHIP CHECK TO UNITED NEGRO COLLEGE FUND
Next Article:GOODYEAR ATTACKS J.D. POWER SURVEY
Topics:


Related Articles
AMERICAN HOME PRODUCTS AND ELI LILLY AND COMPANY ANNOUNCE MARKETING AGREEMENT
TELIOS PHARMACEUTICALS SIGNS AN AGREEMENT WITH LILLY TO DEVELOP NOVEL OSTEOPOROSIS THERAPEUTICS
JACOBS TO PROVIDE PILOT PLANT EXPANSION FOR ELI LILLY AND COMPANY
IBAH EXPANDS DRUG DEVELOPMENT EFFORTS
LILLY AND RANBAXY FORM A GLOBAL ALLIANCE
ATRIX SIGNS RESEARCH AGREEMENT WITH LILLY
CENTOCOR TO REACQUIRE REOPRO MARKETING RIGHTS IN JAPAN
Pharmagenesis, Lilly Sign Research Agreement to Develop Antifungal Drugs
Lilly and Emisphere Enter Into a Strategic Alliance for the Oral Delivery of Proteins
Phytera and Lilly Sign Research Collaboration Agreement to Discover and Develop Infectious Disease Products

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters